Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Stro crawled time : 00:00 save search
VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
Published: 2023-12-04 (Crawled : 00:00) - globenewswire.com
PCVX | $61.98 0.62% 240K
|
Health Technology
|
| O: -0.15%
H: 1.65%
C: -0.72%
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: -0.7%
H: 1.05%
C: -0.35%
vax-24 candidate pneumococcal vaccine lancet potential
Vaxcyte to Host Webcast and Conference Call to Discuss Results from Phase 2 Study of its 24-Valent Pneumococcal Conjugate Vaccine Candidate in Adults Aged 65 and Older and Full Six-Month Safety Data from Both Adult Phase 2 Studies
Published: 2023-04-16 (Crawled : 00:00) - globenewswire.com
PCVX | $61.98 0.62% 240K
|
Health Technology
|
| O: 15.18%
H: 6.42%
C: 0.71%
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.68%
H: 8.13%
C: 5.64%
candidate conference pneumococcal vaccine results study phase 2
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers – Molecular Cancer Therapeutics – AACR Journals
Published: 2023-02-07 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -3.99%
stro-002 treatment therapeutics molecular cancer aacr journals
Vaxcyte to Host Webcast and Conference Call to Discuss Topline Results from the Phase 1/2 Proof-of-Concept Study of VAX-24 Being Investigated for the Prevention of Invasive Pneumococcal Disease in Adults
Published: 2022-10-23 (Crawled : 00:00) - globenewswire.com
PCVX | $61.98 0.62% 240K
|
Health Technology
|
| O: 70.8%
H: 2.7%
C: -6.12%
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.71%
H: 14.96%
C: 13.91%
vax-24 conference disease topline study pneumococcal
Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs)
Published: 2022-06-27 (Crawled : 00:00) - globenewswire.com
ALPMF | News | $9.75 200
|
Health Technology
|
| O: 5.56%
H: 0.0%
C: 0.0%
ALPMY | News | $9.53 690K
|
Manufacturing
|
| O: 1.88%
H: 0.0%
C: -0.68%
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 15.01%
H: 14.86%
C: 5.02%
collaboration drug
Senior Director, Bioanalytics
Published: 2021-09-23 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
analytics
Senior Director, Pharmacometrics
Published: 2021-09-23 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
Facilities Mechanic, R&D Site
Published: 2021-09-22 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: -1.05%
Contract Manufacturing Associate
Published: 2021-07-14 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: -0.41%
H: 4.14%
C: 1.63%
contract
Senior Facilities Engineer
Published: 2021-06-16 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.16%
H: 3.6%
C: 2.18%
Scientist, Analytical & Formulation Development
Published: 2021-05-28 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.11%
H: 2.31%
C: -2.26%
Research Associate, Protein Engineering
Published: 2021-04-12 (Crawled : 00:00) - sutrobio.com
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 1.04%
H: 0.82%
C: -1.79%
research
Sutro Biopharma Announces Closing of Upsized $144.9 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares
Published: 2020-12-11 (Crawled : 00:00) - biospace.com/
STRO | $3.815 1.19% 410K
|
Health Technology
|
| O: 0.05%
H: 1.83%
C: -1.03%
offering biopharma
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.21 41.67% 5.6M
|
Technology Services
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
PALI | $6.29 27.59% 22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.